Hayden Panettiere’s account of losing support after speaking openly about postpartum depression has taken on new weight after her death. The renewed criticism centers on what she said happened behind the scenes at Neutrogena, not on a response from the brand.
Hayden Panettiere died at 36 in Greenville, South Carolina, and her death has sparked renewed backlash against Neutrogena. The criticism concerns Panettiere’s allegation that Neutrogena tried to end their longtime partnership after she spoke publicly about postpartum depression, reopening questions about how major brands respond when celebrity ambassadors discuss mental health.
Panettiere shared the allegation in her 2026 memoir and in interviews during the final months of her life. Neutrogena, a Kenvue-owned skincare brand, had not publicly responded to requests for comment cited by USA TODAY and other outlets when her claims surfaced in May.
Why old comments are resurfacing
For years, Panettiere was closely associated with Neutrogena. She said on Jay Shetty’s On Purpose podcast that she had worked with the company for roughly a decade and believed it had supported her through periods of harsh public attention earlier in her career.
That history made her account of the alleged split especially painful. Panettiere said the brand wanted to “fire” her after a 2015 appearance on Live with Kelly and Michael, when she spoke candidly about experiencing postpartum depression.
She said the discussion was not planned. It arose naturally during the interview, she said, because of similarities between her own experience and that of Juliette Barnes, her character on Nashville.
After Panettiere’s death on Aug. 16, social-media users began sharing those interviews again. USA TODAY reported that some commenters urged a boycott, while criticism appeared beneath Neutrogena posts across platforms. A Reddit post calling for a boycott received more than 2,500 upvotes, according to the outlet.
Panettiere’s allegation against Neutrogena
Panettiere’s account was specific, but it remains an allegation. She said that, after the television interview, a representative told her Neutrogena wanted to terminate the partnership because the postpartum-depression discussion had violated a morals clause.
She recalled being told that ending the agreement on that basis was not lawful and said her representative prevented it from happening immediately. Still, Panettiere said she understood that her relationship with the brand was nearing its end.
Her deeper hurt, she said, was the silence that followed. In a May interview with Us Weekly, Panettiere said that after 10 years with the company, she did not hear a farewell or message of support when the arrangement concluded.
“Of all the things” she might have expected a brand to object to, she told Shetty, speaking openly about postpartum depression was the last. She said she did not regret addressing it publicly despite the professional fallout she believed followed.
A public conversation about postpartum depression
The backlash has resonated because Panettiere did more than disclose a diagnosis. She described postpartum depression as real, frightening and deserving of support at a time when she felt the condition was widely misunderstood.
On Live with Kelly and Michael in September 2015, she said postpartum depression could be “completely uncontrollable” and painful. Her words arrived less than a year after the birth of her daughter, Kaya.
In later interviews, Panettiere described a traumatic birth and the difficult mental-health and substance-use struggles that followed. She said she eventually sought treatment and made the painful decision to relinquish custody of Kaya to her former fiancé, Wladimir Klitschko.
Those disclosures help explain why the Neutrogena allegation has drawn such an emotional response. To critics, the possibility that a spokesperson could face career consequences for discussing postpartum depression feels at odds with the public language of wellness and self-care used across the beauty industry.
What Neutrogena has and has not said
There is an important limit to the public record: Panettiere told her side of the story, but Neutrogena did not provide a public account addressing her allegations. USA TODAY reported that it sought comment from the company after her death.
The outlet also noted that Neutrogena did not respond to requests for comment from TMZ, Us Weekly and Page Six when Panettiere discussed the matter in May. Without a direct response, there is no independent public explanation of the contract terms, internal conversations or timing of the partnership’s end.
That absence has fueled the online reaction, but it should also shape how the controversy is understood. A wave of comments and boycott calls can demonstrate public outrage; it cannot by itself establish what occurred in private negotiations more than a decade ago.
For Neutrogena, the issue is now as much about corporate accountability and communication as it is about an old endorsement deal. Silence can leave a brand exposed to the interpretation that it has chosen not to dispute a serious claim.
The legacy behind the backlash
Panettiere said in a May interview with The Hollywood Reporter that she hoped speaking about the Neutrogena episode would make it less likely that someone else in the industry would be treated similarly. That hope now gives the renewed scrutiny a different meaning.
The strongest criticism of Neutrogena is rooted in the belief that speaking honestly about postpartum depression should not jeopardize a woman’s career. The competing view is that the public still lacks the company’s response and the underlying agreement, making definitive judgments about the alleged contractual dispute difficult.
Both points can be true: Panettiere’s account has prompted a meaningful conversation about stigma, while key facts about the former partnership remain unavailable. Her death has made that unresolved record feel more consequential to fans who remember her as one of the most recognizable faces of the brand.
The immediate question is whether Neutrogena will address the allegations directly. Until then, the online backlash is likely to remain focused on the painful contradiction Panettiere described: a skincare partnership associated with confidence and care, and her belief that it turned away when she spoke about a deeply human health struggle.
Leave a Reply